Portfolio company
Reprieve Cardiovascular
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops automated fluid management systems to manage decongestion in patients with acute decompensated heart failure.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
preCARDIA
This company develops catheter-based systems for heart failure specialists to treat patients suffering from acute decompensated heart failure and volume overload.
Corvia Medical
This company develops an atrial shunt to treat patients suffering from heart failure with preserved or mildly reduced ejection fraction.
HeartKinetics
This digital health company develops non-invasive remote monitoring devices and applications for patients and cardiologists to detect and manage heart failure symptoms.
Alleviant Medical
This medical device company develops a minimally invasive interatrial shunt therapy without a permanent implant to treat patients suffering from heart failure.
Haermonics
This company develops automated pericardial flushing systems to prevent blood clots and drainage complications for patients recovering from open-heart surgery.
Alleviant
Alleviant develops a minimally invasive interatrial shunt system to reduce left atrial pressure for patients suffering from chronic heart failure.
Cardiosense
Cardiosense develops noninvasive wearable sensors and software for clinicians to monitor cardiac filling pressure and manage patients with heart failure.
V-Wave
This company develops implantable interatrial shunts to regulate heart pressure and reduce hospitalisations for patients suffering from chronic heart failure.
